143 related articles for article (PubMed ID: 34082071)
21. FuGePrior: A novel gene fusion prioritization algorithm based on accurate fusion structure analysis in cancer RNA-seq samples.
Paciello G; Ficarra E
BMC Bioinformatics; 2017 Jan; 18(1):58. PubMed ID: 28114882
[TBL] [Abstract][Full Text] [Related]
22. Molecular Approaches to Diagnosis in Ewing Sarcoma: Targeted RNA Sequencing.
Salguero-Aranda C; Diaz-Martin J
Methods Mol Biol; 2021; 2226():105-116. PubMed ID: 33326096
[TBL] [Abstract][Full Text] [Related]
23. Fast and sensitive validation of fusion transcripts in whole-genome sequencing data.
Hafstað V; Häkkinen J; Persson H
BMC Bioinformatics; 2023 Sep; 24(1):359. PubMed ID: 37741966
[TBL] [Abstract][Full Text] [Related]
24. Analytical and Clinical Validation of Expressed Variants and Fusions From the Whole Transcriptome of Thyroid FNA Samples.
Angell TE; Wirth LJ; Cabanillas ME; Shindo ML; Cibas ES; Babiarz JE; Hao Y; Kim SY; Walsh PS; Huang J; Kloos RT; Kennedy GC; Waguespack SG
Front Endocrinol (Lausanne); 2019; 10():612. PubMed ID: 31572297
[No Abstract] [Full Text] [Related]
25. Uncovering Clinically Relevant Gene Fusions with Integrated Genomic and Transcriptomic Profiling of Metastatic Cancers.
Tsang ES; Grisdale CJ; Pleasance E; Topham JT; Mungall K; Reisle C; Choo C; Carreira M; Bowlby R; Karasinska JM; MacMillan D; Williamson LM; Chuah E; Moore RA; Mungall AJ; Zhao Y; Tessier-Cloutier B; Ng T; Sun S; Lim HJ; Schaeffer DF; Renouf DJ; Yip S; Laskin J; Marra MA; Jones SJM; Loree JM
Clin Cancer Res; 2021 Jan; 27(2):522-531. PubMed ID: 33148671
[TBL] [Abstract][Full Text] [Related]
26. Overview of Fusion Detection Strategies Using Next-Generation Sequencing.
Schröder J; Kumar A; Wong SQ
Methods Mol Biol; 2019; 1908():125-138. PubMed ID: 30649725
[TBL] [Abstract][Full Text] [Related]
27. Integration of Technical, Bioinformatic, and Variant Assessment Approaches in the Validation of a Targeted Next-Generation Sequencing Panel for Myeloid Malignancies.
Thomas M; Sukhai MA; Zhang T; Dolatshahi R; Harbi D; Garg S; Misyura M; Pugh T; Stockley TL; Kamel-Reid S
Arch Pathol Lab Med; 2017 Jun; 141(6):759-775. PubMed ID: 28557600
[TBL] [Abstract][Full Text] [Related]
28. RNA-seq Fusion Detection in Clinical Oncology.
Hedges DJ
Adv Exp Med Biol; 2022; 1361():163-175. PubMed ID: 35230688
[TBL] [Abstract][Full Text] [Related]
29. Discovery of clinically relevant fusions in pediatric cancer.
LaHaye S; Fitch JR; Voytovich KJ; Herman AC; Kelly BJ; Lammi GE; Arbesfeld JA; Wijeratne S; Franklin SJ; Schieffer KM; Bir N; McGrath SD; Miller AR; Wetzel A; Miller KE; Bedrosian TA; Leraas K; Varga EA; Lee K; Gupta A; Setty B; Boué DR; Leonard JR; Finlay JL; Abdelbaki MS; Osorio DS; Koo SC; Koboldt DC; Wagner AH; Eisfeld AK; Mrózek K; Magrini V; Cottrell CE; Mardis ER; Wilson RK; White P
BMC Genomics; 2021 Dec; 22(1):872. PubMed ID: 34863095
[TBL] [Abstract][Full Text] [Related]
30. Detecting disease-defining gene fusions in unclassified round cell sarcomas using anchored multiplex PCR/targeted RNA next-generation sequencing-Molecular and clinicopathological characterization of 16 cases.
Mantilla JG; Ricciotti RW; Chen E; Hoch BL; Liu YJ
Genes Chromosomes Cancer; 2019 Oct; 58(10):713-722. PubMed ID: 31033080
[TBL] [Abstract][Full Text] [Related]
31. The NAB2-STAT6 gene fusion in solitary fibrous tumor can be reliably detected by anchored multiplexed PCR for targeted next-generation sequencing.
Guseva NV; Tanas MR; Stence AA; Sompallae R; Schade JC; Bossler AD; Bellizzi AM; Ma D
Cancer Genet; 2016; 209(7-8):303-12. PubMed ID: 27292373
[TBL] [Abstract][Full Text] [Related]
32. The use of exome capture RNA-seq for highly degraded RNA with application to clinical cancer sequencing.
Cieslik M; Chugh R; Wu YM; Wu M; Brennan C; Lonigro R; Su F; Wang R; Siddiqui J; Mehra R; Cao X; Lucas D; Chinnaiyan AM; Robinson D
Genome Res; 2015 Sep; 25(9):1372-81. PubMed ID: 26253700
[TBL] [Abstract][Full Text] [Related]
33. Detection of gene fusions using targeted next-generation sequencing: a comparative evaluation.
Heydt C; Wölwer CB; Velazquez Camacho O; Wagener-Ryczek S; Pappesch R; Siemanowski J; Rehker J; Haller F; Agaimy A; Worm K; Herold T; Pfarr N; Weichert W; Kirchner T; Jung A; Kumbrink J; Goering W; Esposito I; Buettner R; Hillmer AM; Merkelbach-Bruse S
BMC Med Genomics; 2021 Feb; 14(1):62. PubMed ID: 33639937
[TBL] [Abstract][Full Text] [Related]
34. Improved detection of clinically relevant fusion transcripts in cancer by machine learning classification.
Hafstað V; Häkkinen J; Larsson M; Staaf J; Vallon-Christersson J; Persson H
BMC Genomics; 2023 Dec; 24(1):783. PubMed ID: 38110872
[TBL] [Abstract][Full Text] [Related]
35. Principles of analytical validation of next-generation sequencing based mutational analysis for hematologic neoplasms in a CLIA-certified laboratory.
Kanagal-Shamanna R; Singh RR; Routbort MJ; Patel KP; Medeiros LJ; Luthra R
Expert Rev Mol Diagn; 2016; 16(4):461-72. PubMed ID: 26765348
[TBL] [Abstract][Full Text] [Related]
36. The landscape and therapeutic relevance of cancer-associated transcript fusions.
Yoshihara K; Wang Q; Torres-Garcia W; Zheng S; Vegesna R; Kim H; Verhaak RG
Oncogene; 2015 Sep; 34(37):4845-54. PubMed ID: 25500544
[TBL] [Abstract][Full Text] [Related]
37. Simultaneous detection of lung fusions using a multiplex RT-PCR next generation sequencing-based approach: a multi-institutional research study.
Vaughn CP; Costa JL; Feilotter HE; Petraroli R; Bagai V; Rachiglio AM; Marino FZ; Tops B; Kurth HM; Sakai K; Mafficini A; Bastien RRL; Reiman A; Le Corre D; Boag A; Crocker S; Bihl M; Hirschmann A; Scarpa A; Machado JC; Blons H; Sheils O; Bramlett K; Ligtenberg MJL; Cree IA; Normanno N; Nishio K; Laurent-Puig P
BMC Cancer; 2018 Aug; 18(1):828. PubMed ID: 30115026
[TBL] [Abstract][Full Text] [Related]
38. Identification of novel fusion transcripts in multiple myeloma.
Lin M; Lee PL; Chiu L; Chua C; Ban KHK; Lin AHF; Chan ZL; Chung TH; Yan B; Chng WJ
J Clin Pathol; 2018 Aug; 71(8):708-712. PubMed ID: 29453220
[TBL] [Abstract][Full Text] [Related]
39. RNA-Seq for the detection of gene fusions in solid tumors: development and validation of the JAX FusionSeq™ 2.0 assay.
Bergeron D; Chandok H; Nie Q; Prego M; Soucy M; Kelly K; Ananda G; Hesse A; Reddi HV
J Mol Med (Berl); 2022 Feb; 100(2):323-335. PubMed ID: 35013752
[TBL] [Abstract][Full Text] [Related]
40. Detection of Gene Fusion Transcripts in Peripheral T-Cell Lymphoma Using a Multiplexed Targeted Sequencing Assay.
Drieux F; Ruminy P; Sater V; Marchand V; Fataccioli V; Lanic MD; Viennot M; Viailly PJ; Sako N; Robe C; Dupuy A; Vallois D; Veresezan L; Poullot E; Picquenot JM; Bossard C; Parrens M; Lemonnier F; Jardin F; de Leval L; Gaulard P
J Mol Diagn; 2021 Aug; 23(8):929-940. PubMed ID: 34147695
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
